Navigation Links
Savient Announces Appointment of David Gionco as Chief Financial Officer
Date:2/12/2009

EAST BRUNSWICK, N.J., Feb. 12 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced the appointment of David G. Gionco to the position of Vice President, Chief Financial Officer & Treasurer. Mr. Gionco replaces Brian Hayden, who has been terminated as Savient's Chief Financial Officer, effective immediately.

"We are pleased to announce David's appointment. As our current Vice President of Corporate Finance and Controller, David will be able to seamlessly step in as Chief Financial Officer. Since joining Savient in 2006, David has distinguished himself as a true leader in the financial and operational areas. David's experience and dedication makes him well-suited to lead our finance and accounting departments. I look forward to working with David in the months ahead as we continue to move through the FDA regulatory process and towards what we hope will be a successful approval of KRYSTEXXA(TM) (pegloticase)," said Paul Hamelin, President, Savient Pharmaceuticals.

Mr. Gionco has spent more than 18 years in the pharmaceutical industry, including the past three years with Savient where he most recently served as Vice President of Corporate Finance and Controller. Through his career, Mr. Gionco has held various audit, corporate accounting, financial planning, finance and controller roles of increasing responsibility at companies including Medco, Merck & Co., Progenics Pharmaceuticals and Odyssey Pharmaceuticals, where he served as Acting Chief Financial Officer/Director of Finance and Controller before joining Savient. In addition, Mr. Gionco has 7 years of financial auditing experience with a major public accounting firm. Mr. Gionco holds a B.S. in Accounting from Fairleigh Dickinson University and an MBA from Rutgers University.

A
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th
2. Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results
3. Savient Submits Biologics License Application (BLA) for pegloticase
4. Savients Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference
5. Savient Pharmaceuticals to Hold Third Quarter 2008 Financial Results Conference Call on Thursday, November 6, 2008
6. Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer
7. SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS
8. Genesis Pharmaceuticals Announces Conference Call to Discuss Results for its Second Quarter of FY 2009
9. Cord Blood Announces $1 Million Reduction in Long Term Debt
10. BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors
11. XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Terascala, the industry leader in ... a former vice president of product management for Flexera ... of marketing. Terascala’s software when combined with leading compute ... highest performance and most reliable solutions for processing big ... channel expansion and broaden its product portfolio. His leadership ...
(Date:7/10/2014)... 2014 Robert Harman, DVM, Founder and CEO ... proud to announce the relaunch of his highly informative blog, ... series called “ What are Stem Cells ?” Dr. ... straightforward foundation in the basics of stem cell therapy so ... right type of treatment when considering regenerative medicine. , A ...
(Date:7/10/2014)... EvoDerma ’s NOOME Anti-Aging Motion has been upgraded ... with a second treatment cup to help prevent and smooth ... is thinner on the edges for a softer contact with ... uneven surfaces on the face, neck and décolleté. Choose to ... areas such as the cheeks and neck, or opt for ...
(Date:7/10/2014)... POINT, Ind. , July 10, 2014 ... expanded its use of capnography for respiratory ... growing group of healthcare leaders in embracing ... measures how effectively patients are breathing and ... depression occurs. By measuring the amount of ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2
... MELBOURNE, Australia, Oct. 5 Cytopia Limited (ASX: CYT) ... BioSciences Inc. ("YM") have signed an exclusive and binding ... YM will acquire all of the issued shares and ... scheme(s) of arrangement ("Scheme(s)") and shareholders (and optionholders if ...
... Corporation (NYSE: BSX ) today announced its exclusive ... This new trial follows in the tradition of ... each exclusively sponsored by Boston Scientific and conducted under ... Professor of Medicine at the University of Rochester. , ...
... , UPPSALA, Sweden, October 5 ... SuperConvection(TM), - At One Sixth the Price of ... of PCR Expected to Rapidly Penetrate the Market , ... developed a,miniaturized PCR-instrument - AmpXpress(TM) - to meet demands for lower,instrument ...
Cached Biology Technology:Cytopia Merger with Toronto-based YM BioSciences Inc. 2Cytopia Merger with Toronto-based YM BioSciences Inc. 3Cytopia Merger with Toronto-based YM BioSciences Inc. 4Cytopia Merger with Toronto-based YM BioSciences Inc. 5Cytopia Merger with Toronto-based YM BioSciences Inc. 6Cytopia Merger with Toronto-based YM BioSciences Inc. 7Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial 2Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial 3AlphaHelix Presents AmpXpress(TM) at the BIOTECHNICA Show 2
(Date:7/10/2014)... , July 1, 2014 Smart ... way for convenience and improved security: NXT-ID, Inc. (OTCBB: NXTD), ... GOOG ), Apple Inc. (NASDAQ: AAPL ... Corporation (NYSE: MA) NXT-ID, Inc., (OTCQB: NXTD) a biometric ... to announce that the second series of 30 second spots ...
(Date:7/10/2014)... COMMACK, N.Y. , July 2, 2014 ... Inc. (ABD) to announce the appointment of the world-renowned ... its Board of Directors. Dr. Ginsburg, with ... two facilities: NY Presbyterian Hospital and Good Samaritan Regional ... Breathing Pacemaker since the late 1980,s and is considered ...
(Date:7/10/2014)... According to the new market research report, ... (Optical Prism, Pizeoelectric, Capacitive, and Adhesives), Application (Mobile Devices, ... and Geography - Global Trends & Forecasts to 2014 ... Market is projected to cross $14.35 Billion by 2020, ... to 2020. Browse more than 78 market ...
Breaking Biology News(10 mins):Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2Fingerprint Sensors Market worth $14.35 Billion by 2020 2Fingerprint Sensors Market worth $14.35 Billion by 2020 3
... presents Research & Entrepreneurship Day on April 30th, 2010 ... Stevens campus. R&E Day is a showcase of ... and student based research programs. It is also ... success in engineering solutions for the betterment of mankind. ...
... Tech biologist proposes to use a physics strategy called resonant ... they will be sensitive to antibiotics. In medicine, resonance ... thumps your chest. In physics, resonance is a periodic force ... a natural system,s frequency. Sound waves are an example of ...
... , A new study identifies cattle feed as a ... San Joaquin Valley a moderately-populated agricultural region ... ingredients in smog) than many densely-populated cities. The report, ... exhausts in forming ozone, is in ACS, Environmental ...
Cached Biology News:Research & Entrepreneurship Day 2010: Engineering Innovation 2Physics strategy tested as solution for antibiotic resistance 2
... Microarrays designed for genome-wide microRNA ... flexible and powerful Paraflo microfluidic on-chip ... as part of our comprehensive microRNA ... Content The Soil Nematode microRNA ...
... to the maintenance of appropriate levels ... important and diverse as those involved ... stress response, antigen presentation, modulation of ... cell cycle regulation, transcription, and signalling ...
... modified digital scanner serves as the spot-picking ... five standard rack positions on the tray, ... well plates on the remaining two racks.,The ... spots by mouse-click on the scanned gel ...
... Cleanroom-grade vinyl curtains or ... powder-coated steel support frame to ... cleanroom that meets cleanliness to ... HEPA filter/fan units, lights, and ...
Biology Products: